Fingerprint
Dive into the research topics of 'Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer
Howard H. Bailey, Steven Attia, Richard R. Love, Terri Fass, Rick Chappell, Kendra Tutsch, Linda Harris, Alcee Jumonville, Richard Hansen, Gary R. Shapiro, James A. Stewart
Research output: Contribution to journal › Article › peer-review
53
Scopus
citations